Lorbriqua 100mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Lorlatinib (100mg)
Overview Lorbriqua 100mg Tablet
Enlorta 100mg tablets are indicated for treating adults with advanced, recurrent, or surgically inoperable non-small cell lung cancer (NSCLC). Its mechanism involves anaplastic lymphoma kinase (ALK) enzyme inhibition, specifically for patients exhibiting ALK genetic abnormalities. This medication is reserved for NSCLC patients who have shown resistance to prior ALK inhibitors like alectinib or ceritinib. Furthermore, Enlorta 100mg tablets effectively manage ALK-positive NSCLC with brain metastases. Administer with or without food, consistently at the same time daily. Dosage adjustments or temporary treatment interruptions may occur based on individual response and clinical status. Continue therapy as directed; abrupt cessation is discouraged. Potential side effects include peripheral edema (swelling in extremities), peripheral neuropathy (numbness/tingling in limbs), and cognitive impairment (confusion, memory loss, decreased concentration). Additional adverse effects can encompass shortness of breath, fatigue, weight increase, arthralgia, mood alterations, and diarrhea. Report concerning or intensifying side effects to your physician; dosage modifications or management strategies may be implemented. Prior to commencing treatment, disclose any pre-existing conditions, including renal or cardiac disease, depression, seizures, arrhythmias, respiratory issues, hypertension, hypercholesterolemia, and diabetes. Pregnant or lactating individuals should consult their physician before initiating Enlorta 100mg tablet therapy. Drug interactions are possible; inform your physician of all concurrent medications.
Primary Ingredients of Lorbriqua 100mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Lorbriqua 100mg Tablet
Managing non-small cell lung carcinoma
Major Benefits of Lorbriqua 100mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 100mg Lorbriqua tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended.
Common Side effects of Lorbriqua 100mg Tablet:
- Fatigue
- Diarrhea
- Edema (swelling)
- High blood pressure
- Cough
- Joint pain
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Weight gain
- Breathlessness
- Mood changes
- Hypercholesterolemia (high cholesterol)
- Increased triglyceride level in blood
How to use Lorbriqua 100mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 100mg Lorbriqua tablet whole; avoid chewing, crushing, or breaking it. While you can take it with or without food, consistency in timing is recommended.
How Lorbriqua 100mg Tablet works:
Oncaspar 100mg tablets are a cancer treatment that inhibits the activity of a mutated protein responsible for cancerous cell proliferation, thereby hindering or slowing tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lorbriqua 100mg tablets may be unsafe; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Lorbriqua 100mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingCAUTION
Use of Lorbriqua 100mg Tablets necessitates careful consideration during lactation. Mothers should discontinue breastfeeding throughout their treatment course and until the medication is fully cleared from their system.
DrivingCONSULT YOUR DOCTOR
Driving ability while taking Lorbriqua 100mg Tablet is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Lorbriqua 100mg tablets to individuals with severely impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. No dosage alteration is advised for patients exhibiting mild or moderate kidney dysfunction.
LiverSAFE IF PRESCRIBED
Lorbriqua 100mg tablets are considered safe for use by individuals with liver disease, and no dosage alteration is typically advised. Nevertheless, dosing guidelines for patients experiencing moderate to severe liver dysfunction have not yet been determined.
What if you forget to take Lorbriqua 100mg Tablet :
NA
Facts to Know About Lorbriqua 100mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenylpropanoid compounds |
| Developing Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | TKIs (tyrosine kinase inhibitors) |
3,018 People bought this recently